iANTHUS CAPITAL HOLDINGS (ITHUF) Accounts Payables (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Accounts Payables came in at $16.7 million in Q1 2026, up 48.67% year-on-year from $11.2 million in Q1 2025, and up 2.75% quarter-over-quarter from $16.3 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Accounts Payables (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Accounts Payables across 7 years of filings, most recently posting $16.7 million for Q1 2026.
- Accounts Payables for Q1 2026 came in at $16.7 million, up 48.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.7 million (up 48.67% YoY), and the FY2025 annual result was $16.3 million, up 26.78% from the prior year.
- Accounts Payables came in at $16.7 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $16.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $17.3 million in Q1 2022 to a low of $10.2 million in Q3 2025.
- The 5-year median for Accounts Payables is $14.4 million (2024), against an average of $13.9 million.
- Across the five-year window, Accounts Payables tumbled 32.45% in 2023 and soared 48.67% in 2026, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Accounts Payables stood at $10.7 million in 2022, then surged by 34.7% to $14.4 million in 2023, then fell by 10.89% to $12.8 million in 2024, then rose by 26.78% to $16.3 million in 2025, then advanced by 2.75% to $16.7 million in 2026.
- The last three Accounts Payables figures came in at $16.7 million (Q1 2026), $16.3 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 16.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.71 Mn |
| Dec 31, 2025 | 16.27 Mn |
| Sep 30, 2025 | 10.21 Mn |
| Jun 30, 2025 | 14.48 Mn |
| Mar 31, 2025 | 11.24 Mn |
| Dec 31, 2024 | 12.83 Mn |
| Sep 30, 2024 | 14.44 Mn |
| Jun 30, 2024 | 15.40 Mn |
| Mar 31, 2024 | 14.45 Mn |
| Dec 31, 2023 | 14.40 Mn |
| Sep 30, 2023 | 16.42 Mn |
| Jun 30, 2023 | 15.67 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 10.69 Mn |
| Sep 30, 2022 | 11.44 Mn |
| Jun 30, 2022 | 12.88 Mn |
| Mar 31, 2022 | 17.30 Mn |
| Dec 31, 2021 | 13.64 Mn |
| Sep 30, 2021 | 13.03 Mn |
| Jun 30, 2021 | 11.19 Mn |